Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-25-001381
Filing Date
2025-01-17
Accepted
2025-01-17 16:07:37
Documents
14

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 pirs20250115c_424b3.htm 424B3 4864589
2 image01.jpg GRAPHIC 6824
3 image02.jpg GRAPHIC 17732
4 image03.jpg GRAPHIC 26983
5 image04.jpg GRAPHIC 29696
6 image05.jpg GRAPHIC 23486
7 image06.jpg GRAPHIC 52915
8 image07.jpg GRAPHIC 88864
9 image08.jpg GRAPHIC 118079
10 image09.jpg GRAPHIC 41782
11 image10.jpg GRAPHIC 18385
12 image11.jpg GRAPHIC 62205
13 image12.jpg GRAPHIC 57720
14 image13.jpg GRAPHIC 20696
  Complete submission text file 0001437749-25-001381.txt   5645984
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284093 | Film No.: 25538735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)